American Century Companies Inc Arcus Biosciences, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 87,982 shares of RCUS stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,982

Previous 70,917 24.06%

Holding current value

$1.29 Million

Previous $1.08 Million 24.54%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.69 - $18.01 $233,619 - $307,340	17,065 Added 24.06%	87,982 $1.35 Million
Q2 2024 Aug 07, 2024	BUY	$14.59 - $18.48 $189,947 - $240,591	13,019 Added 22.49%	70,917 $1.08 Million
Q1 2024 May 14, 2024	BUY	$14.83 - $20.18 $91,041 - $123,885	6,139 Added 11.86%	57,898 $1.09 Million
Q4 2023 Feb 13, 2024	BUY	$13.43 - $19.63 $695,123 - $1.02 Million	51,759 New	51,759 $988,000
Q3 2023 Nov 13, 2023	BUY	$17.62 - $23.54 $235,632 - $314,800	13,373 Added 3.01%	457,695 $8.22 Million
Q2 2023 Aug 14, 2023	BUY	$16.97 - $22.03 $5.09 Million - $6.6 Million	299,685 Added 207.2%	444,322 $9.02 Million
Q1 2023 May 11, 2023	BUY	$15.96 - $23.15 $207 - $300	13 Added 0.01%	144,637 $2.64 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $43,812 - $79,419	2,224 Added 1.56%	144,624 $2.99 Million
Q3 2022 Nov 14, 2022	BUY	$23.23 - $30.07 $766 - $992	33 Added 0.02%	142,400 $3.73 Million
Q2 2022 Aug 12, 2022	BUY	$17.23 - $37.73 $424,753 - $930,119	24,652 Added 20.94%	142,367 $3.61 Million
Q1 2022 May 11, 2022	BUY	$28.92 - $41.83 $55,266 - $79,937	1,911 Added 1.65%	117,715 $3.72 Million
Q4 2021 Feb 07, 2022	BUY	$31.38 - $48.47 $2.79 Million - $4.31 Million	88,904 Added 330.5%	115,804 $4.69 Million
Q3 2021 Nov 10, 2021	BUY	$26.93 - $37.68 $478,707 - $669,799	17,776 Added 194.83%	26,900 $938,000
Q2 2021 Aug 05, 2021	SELL	$22.75 - $35.77 $517,266 - $813,302	-22,737 Reduced 71.36%	9,124 $251,000
Q1 2021 May 14, 2021	BUY	$26.16 - $41.39 $313,972 - $496,762	12,002 Added 60.44%	31,861 $895,000
Q4 2020 Feb 12, 2021	SELL	$17.0 - $32.36 $218,586 - $416,084	-12,858 Reduced 39.3%	19,859 $516,000
Q4 2018 Feb 13, 2019	BUY	$9.74 - $14.5 $318,663 - $474,396	32,717 New	32,717 $352,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.06B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Arcus Biosciences, Inc. Transaction History